Spectrum’s Rouvé Looks To Put Charge Into Electrics
More Profiles…
The front-end performance by the national drug chains is under intensifying scrutiny after flat or declining comps the past several months. That threatens to squeeze the growth potential, if it already hasn’t, for housewares in the drug channel.
Click Here to read the full article.
